Apple's Tim Cook: Company Paid More Than $6 Billion to US Treasury Last Year
Johnson & Johnson
featured
 2.240x180.jpg?v=1369079618 "Cramer: Invest Like the Ridiculously Rich")
What would you do with $590 million – here’s how Jim Cramer would invest it!
» Read More
More
-
Allergan fell$. 32 or. 3 percent, to $103.86. Baxter International Inc. fell$. 30 or. 4 percent, to $70.46. Boston Scientific Corp. rose$. 20 or 2.4 percent, to $8.65.
-
Baxter International Inc. fell$. 03 or percent, to $70.74. Bristol-Myers Squibb Co. rose$. 24 or. 6 percent, to $40.73. Hospira fell$. 19 or. 5 percent, to $34.43.
-
Allergan fell$. 18 or. 2 percent, to $104.00. Baxter International Inc. fell$. 03 or percent, to $70.74. Boston Scientific Corp. rose$. 29 or 3.4 percent, to $8.74.
-
MOUNTAIN VIEW, Calif.-- Obesity drug maker Vivus Inc. on Monday named two new directors to its board as it finds itself in a proxy fight. CEO of German drugmaker Boehringer Ingelheim from 2003 to 2011, and Plutzky has directed the vascular disease prevention program at Brigham and Women's Hospital in Boston since 1996..
-
Allergan fell$. 37 or. 4 percent, to $103.82. Baxter International Inc. fell$. 34 or. 5 percent, to $70.42. Medtronic fell$. 02 or percent, to $49.15.
-
Baxter International Inc. fell$. 34 or. 5 percent, to $70.42. Bristol-Myers Squibb Co. rose$. 11 or. 3 percent, to $40.60. Hospira fell$. 19 or. 6 percent, to $34.43.
-
Allergan rose $1.03 or 1.0 percent, to $104.18. Baxter International Inc. fell$. 23 or. 3 percent, to $70.76. Boston Scientific Corp. rose$. 15 or 1.8 percent, to $8.45.
-
Baxter International Inc. fell$. 23 or. 3 percent, to $70.76. Bristol-Myers Squibb Co. rose$. 56 or 1.4 percent, to $40.49. Hospira rose$. 07 or. 2 percent, to $34.62.
-
Baxter International Inc. fell$. 30 or. 4 percent, to $70.69. Bristol-Myers Squibb Co. rose$. 22 or. 6 percent, to $40.15. Hospira rose$. 04 or. 1 percent, to $34.59.
-
Allergan rose$. 38 or. 4 percent, to $103.53. Baxter International Inc. fell$. 30 or. 4 percent, to $70.69. Boston Scientific Corp. rose$. 12 or 1.4 percent, to $8.42.
-
Baxter International Inc. rose$. 03 or percent, to $71.02. Bristol-Myers Squibb Co. rose$. 25 or. 6 percent, to $40.18. Hospira fell$. 02 or. 1 percent, to $34.53.
-
Allergan rose $1.15 or 1.1 percent, to $104.30. Baxter International Inc. rose$. 03 or percent, to $71.02. Boston Scientific Corp. rose$. 23 or 2.8 percent, to $8.53.
-
Baxter International Inc. fell$. 28 or. 4 percent, to $70.99. Bristol-Myers Squibb Co. rose$. 25 or. 6 percent, to $39.93. Hospira rose$. 95 or 2.8 percent, to $34.55.
-
Allergan fell$. 16 or. 2 percent, to $103.15. Baxter International Inc. fell$. 28 or. 4 percent, to $70.99. Boston Scientific Corp. rose$. 45 or 5.7 percent, to $8.30.
-
SEATTLE-- Dendreon Corp. said Thursday that sales of its prostate cancer therapy Provenge fell in the first quarter because of increased competition from two newer drugs. Net revenue from Provenge fell 18 percent to $67.6 million, Dendreon said. Dendreon said it lost $72 million, or 48 cents per share, in the three months ended March 31.
-
Allergan rose$. 46 or. 4 percent, to $103.77. Baxter International Inc. rose$. 02 or percent, to $71.29. Boston Scientific Corp. rose$. 29 or 3.7 percent, to $8.14.
-
Baxter International Inc. rose$. 02 or percent, to $71.29. Bristol-Myers Squibb Co. rose$. 13 or. 3 percent, to $39.81. Hospira rose$. 75 or 2.2 percent, to $34.35.
-
Allergan rose$. 11 or. 1 percent, to $103.42. Baxter International Inc. fell$. 07 or. 1 percent, to $71.20. Boston Scientific Corp. rose$. 21 or 2.6 percent, to $8.06.
-
Baxter International Inc. fell$. 07 or. 1 percent, to $71.20. Bristol-Myers Squibb Co. fell$. 22 or. 6 percent, to $39.46. Hospira rose$. 30 or. 9 percent, to $33.90.
-
Allergan fell $1.43 or 1.4 percent, to $103.31. Baxter International Inc. rose $2.69 or 3.9 percent, to $71.27. Boston Scientific Corp. rose$. 16 or 2.1 percent, to $7.85.